Novozymes A/S Price Chart
Novozymes A/S NZM2.SG Financial and Trading Overview
| Novozymes A/S stock price | 51.56 EUR |
| Previous Close | 45.78 EUR |
| Open | 45.55 EUR |
| Bid | 45.42 EUR x 50000 |
| Ask | 45.53 EUR x 50000 |
| Day's Range | 45.33 - 45.55 EUR |
| 52 Week Range | 44.07 - 62.72 EUR |
| Volume | 0 EUR |
| Avg. Volume | 110 EUR |
| Market Cap | 13.63B EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 31.383127 |
| EPS (TTM) | 1.45 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NZM2.SG Valuation Measures
| Enterprise Value | 11.7B EUR |
| Trailing P/E | 31.383127 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.4263906 |
| Price/Book (mrq) | 8.223994 |
| Enterprise Value/Revenue | 5.515 |
| Enterprise Value/EBITDA | 15.914 |
Trading Information
Novozymes A/S Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -15.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 62.72 EUR |
| 52 Week Low | 44.07 EUR |
| 50-Day Moving Average | 47.03 EUR |
| 200-Day Moving Average | 49.42 EUR |
NZM2.SG Share Statistics
| Avg. Volume (3 month) | 110 EUR |
| Avg. Daily Volume (10-Days) | 65 EUR |
| Shares Outstanding | N/A |
| Float | 220.1M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.53 |
| Trailing Annual Dividend Yield | 1.15% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2015 |
| Most Recent Quarter (mrq) | June 30, 2016 |
| Next Fiscal Year End | December 31, 2017 |
Profitability
| Profit Margin | 20.90% |
| Operating Margin (ttm) | 28.41% |
| Gross Margin | 59.08% |
| EBITDA Margin | 34.65% |
Management Effectiveness
| Return on Assets (ttm) | 13.79% |
| Return on Equity (ttm) | 26.46% |
Income Statement
| Revenue (ttm) | 2.12B EUR |
| Revenue Per Share (ttm) | 6.99 EUR |
| Quarterly Revenue Growth (yoy) | -0.59% |
| Gross Profit (ttm) | 8.43B EUR |
| EBITDA | 735.15M EUR |
| Net Income Avi to Common (ttm) | 443.42M EUR |
| Diluted EPS (ttm) | 1.446 |
| Quarterly Earnings Growth (yoy) | 10.00% |
Balance Sheet
| Total Cash (mrq) | 107.64M EUR |
| Total Cash Per Share (mrq) | 0.36 EUR |
| Total Debt (mrq) | 279.62M EUR |
| Total Debt/Equity (mrq) | 16.85 EUR |
| Current Ratio (mrq) | 1.799 |
| Book Value Per Share (mrq) | 5.518 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 491.71M EUR |
| Levered Free Cash Flow (ttm) | 232.8M EUR |
Profile of Novozymes A/S
| Country | Germany |
| State | N/A |
| City | Bagsvaerd |
| Address | Krogshoejvej 36 |
| ZIP | 2880 |
| Phone | 45 44 46 00 00 |
| Website | https://www.novozymes.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 6385 |
Novozymes A/S produces and sells industrial enzymes, microorganisms, and biopolymers worldwide. It operates through three divisions: Household Care and Technical Industries, Agriculture and Bioenergy, and Food and Beverages. The company offers solutions for the agriculture industry, including enzymes for animal nutrition to enhance digestion processes; probiotics; microbial solutions to maintain water quality that limits risk of disease and enhances yields in aquaculture; and microbial-based biocontrol and bioyield enhancer products to naturally produce healthier crops and enhance yields. It also provides a portfolio of enzymes for application in biofuel production; enzymes for drug delivery and drug formulation; and food and beverages enzymes for applications in baking, brewing, dairy, distilling, flavor enhancement, food specialties, health and nutrition, juice, meat processing, oils and fats, starch, and wine industries. In addition, the company offers household care enzyme and microbial agents for use in cleaning solutions, dishwashing, and laundry; enzymes for biopreparation, degreasing, and re-bating of leather; enzymes for pulp and paper production processes, such as bleach boosting, deinking, drainage enhancement, effluent control, pitch control, refining, slime control, starch modification, and stickies control; enzymatic solutions for processing textiles; and biological wastewater treatment products. Novozymes A/S has a strategic alliance with Monsanto Company to discover, develop, and sell microbial solutions for farmers. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novozymes A/S Stock
What is a current NZM2.SG stock price?
Novozymes A/S NZM2.SG stock price today per share is 51.56 EUR.
How to purchase Novozymes A/S stock?
You can buy NZM2.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novozymes A/S?
The stock symbol or ticker of Novozymes A/S is NZM2.SG.
How many shares does Novozymes A/S have in circulation?
The max supply of Novozymes A/S shares is 300.4M.
What is Novozymes A/S Price to Earnings Ratio (PE Ratio)?
Novozymes A/S PE Ratio is 35.65698600 now.
What was Novozymes A/S earnings per share over the trailing 12 months (TTM)?
Novozymes A/S EPS is 1.45 EUR over the trailing 12 months.